Marco Colleoni
Marco Colleoni
Direttore, Divisione di Senologia Medica, Istituto Europeo di Oncologia, Milano
Verified email at ieo.it
Title
Cited by
Cited by
Year
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
25002013
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
13692015
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
AS Coates, A Keshaviah, B Thurlimann, H Mouridsen, L Mauriac, ...
Journal of clinical oncology 25 (5), 486-492, 2007
9982007
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ...
The lancet oncology 14 (4), 297-305, 2013
8512013
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
M Dowsett, J Cuzick, J Ingle, A Coates, J Forbes, J Bliss, M Buyse, ...
Journal of Clinical Oncology 28 (3), 509-518, 2010
8442010
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous …
M Cristofanilli, NC Turner, I Bondarenko, J Ro, SA Im, N Masuda, ...
The Lancet Oncology 17 (4), 425-439, 2016
8132016
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
O Pagani, MM Regan, BA Walley, GF Fleming, M Colleoni, I Láng, ...
New England Journal of Medicine 371 (2), 107-118, 2014
6282014
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
5692015
Adjuvant ovarian suppression in premenopausal breast cancer
PA Francis, MM Regan, GF Fleming, I Láng, E Ciruelos, M Bellet, ...
New England Journal of Medicine 372 (5), 436-446, 2015
5672015
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
5112017
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
M Colleoni, A Rocca, MT Sandri, L Zorzino, G Masci, F Nole, G Peruzzotti, ...
Annals of Oncology 13 (1), 73-80, 2002
4922002
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents
Y Shaked, E Henke, JML Roodhart, P Mancuso, MHG Langenberg, ...
Cancer cell 14 (3), 263-273, 2008
4482008
Very young women (< 35 years) with operable breast cancer: features of disease at presentation
M Colleoni, N Rotmensz, C Robertson, L Orlando, G Viale, G Renne, ...
Annals of Oncology 13 (2), 273-279, 2002
4462002
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment
M Colleoni, G Viale, D Zahrieh, G Pruneri, O Gentilini, P Veronesi, ...
Clinical Cancer Research 10 (19), 6622-6628, 2004
3932004
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
M Kaufmann, G Von Minckwitz, HD Bear, A Buzdar, P McGale, H Bonnefoi, ...
Annals of Oncology 18 (12), 1927-1934, 2007
3882007
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
O Pagani, E Senkus, W Wood, M Colleoni, T Cufer, S Kyriakides, A Costa, ...
Journal of the National Cancer Institute 102 (7), 456-463, 2010
3292010
Depression and degree of acceptance of adjuvant cytotoxic drugs
M Colleoni, M Mandala, G Peruzzotti, C Robertson, A Bredart, ...
The Lancet 356 (9238), 1326-1327, 2000
3112000
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer
S Dellapasqua, F Bertolini, V Bagnardi, E Campagnoli, E Scarano, ...
Journal of Clinical Oncology 26 (30), 4899-4905, 2008
2982008
Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer
G Curigliano, G Viale, V Bagnardi, L Fumagalli, M Locatelli, N Rotmensz, ...
Journal of clinical oncology 27 (34), 5693-5699, 2009
2822009
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
P Mancuso, M Colleoni, A Calleri, L Orlando, P Maisonneuve, G Pruneri, ...
Blood 108 (2), 452-459, 2006
2772006
The system can't perform the operation now. Try again later.
Articles 1–20